Lee JY, Kim S-A, Yang D-H, Eum H-S, Lee M-W, Lee HJ, Kwak J-Y, Park YH, Do YR, Lee J-O. Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma. haematol [Internet]. 2020Sep.10 [cited 2026Jun.19];. Available from: https://haematologica.org/article/view/14241